Top compounds associated with response to RP11-96L14.7


Feature Type Standardized
Nominal ANOVA
mRNA MK 1775 CTRPv2 pan-cancer AAC -0.09 0.008
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.008
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC -0.088 0.008
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.009
mRNA niclosamide CTRPv2 pan-cancer AAC 0.093 0.01
mRNA KPT185 CTRPv2 pan-cancer AAC -0.097 0.01
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.01
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.094 0.01
mRNA JW-480 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC -0.1 0.01
Download CSV